Morgan Stanley Amarin Corp Plcuk Transaction History

Morgan Stanley

$1.39 Trillion
Q4 2024

A detailed history of Morgan Stanley transactions in Amarin Corp Plcuk stock. As of the latest transaction made, Morgan Stanley holds 4,406,422 shares of AMRN stock, worth $2.69 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

4,406,422

Previous 2,545,752 73.09%

Holding current value

$2.69 Million

Previous $1.6 Million 31.94%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$0.44 - $0.63 $818,694 - $1.17 Million	1,860,670 Added 73.09%	4,406,422 $2.12 Million
Q3 2024 Nov 14, 2024	SELL	$0.57 - $0.8 $9,846 - $13,819	-17,274 Reduced 0.67%	2,545,752 $1.6 Million
Q2 2024 Oct 17, 2024	SELL	$0.63 - $1.07 $659,792 - $1.12 Million	-1,047,289 Reduced 29.01%	2,563,026 $1.77 Million
Q2 2024 Aug 14, 2024	SELL	$0.63 - $1.07 $659,792 - $1.12 Million	-1,047,289 Reduced 29.01%	2,563,026 $1.77 Million
Q1 2024 Oct 17, 2024	BUY	$0.82 - $1.35 $858,776 - $1.41 Million	1,047,289 Added 40.86%	3,610,315 $3.21 Million
Q1 2024 Aug 16, 2024	SELL	$0.82 - $1.35 $1.6 Million - $2.64 Million	-1,952,768 Reduced 35.1%	3,610,315 $3.21 Million
Q1 2024 May 15, 2024	SELL	$0.82 - $1.35 $1.6 Million - $2.64 Million	-1,952,768 Reduced 35.1%	3,610,315 $3.21 Million
Q4 2023 Aug 16, 2024	BUY	$0.66 - $0.91 $1.98 Million - $2.73 Million	3,000,057 Added 117.05%	5,563,083 $4.84 Million
Q4 2023 Feb 13, 2024	SELL	$0.66 - $0.91 $3.36 Million - $4.64 Million	-5,097,382 Reduced 47.82%	5,563,083 $4.84 Million
Q3 2023 Nov 15, 2023	SELL	$0.85 - $1.43 $524,152 - $881,809	-616,650 Reduced 5.47%	10,660,465 $9.81 Million
Q2 2023 Aug 14, 2023	SELL	$1.12 - $1.49 $305,508 - $406,434	-272,775 Reduced 2.36%	11,277,115 $13.4 Million
Q1 2023 May 15, 2023	SELL	$1.19 - $2.19 $12.5 Million - $22.9 Million	-10,478,005 Reduced 47.57%	11,549,890 $17.3 Million
Q4 2022 Feb 14, 2023	BUY	$1.07 - $1.34 $17.5 Million - $21.9 Million	16,373,362 Added 289.56%	22,027,895 $26.7 Million
Q3 2022 Nov 14, 2022	BUY	$1.09 - $1.67 $345,238 - $528,944	316,733 Added 5.93%	5,654,533 $6.16 Million
Q2 2022 Oct 27, 2022	BUY	$1.13 - $3.69 $790,502 - $2.58 Million	699,560 Added 15.08%	5,337,800 $7.95 Million
Q2 2022 Aug 15, 2022	BUY	$1.13 - $3.69 $790,502 - $2.58 Million	699,560 Added 15.08%	5,337,800 $7.95 Million
Q1 2022 Oct 27, 2022	SELL	$2.85 - $3.73 $1.99 Million - $2.61 Million	-699,560 Reduced 13.11%	4,638,240 $15.3 Million
Q1 2022 May 13, 2022	SELL	$2.85 - $3.73 $552,828 - $723,526	-193,975 Reduced 4.01%	4,638,240 $15.3 Million
Q4 2021 Feb 14, 2022	SELL	$3.24 - $5.18 $4.87 Million - $7.79 Million	-1,504,191 Reduced 23.74%	4,832,215 $16.3 Million
Q3 2021 Nov 15, 2021	BUY	$3.94 - $5.84 $25 Million - $37 Million	6,336,406 New	6,336,406 $32.3 Million

Others Institutions Holding AMRN

# of Institutions

181

Shares Held

68.6M

Call Options Held

192K

Put Options Held

78.1K

View Full List

About AMARIN CORP PLCUK

Ticker AMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 403,206,016
Market Cap $246M
Description
Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...

More about AMRN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Account